Robert Bailey, MD
Surgery · Florence, ALNPI 1306804786
Payments from drug & device makers
Across 54 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$289
- Merit Medical Systems Inc$114
- TELA Bio, Inc.$113
- Elucent Medical$81
- Davol Inc.$70
- Johnson & Johnson$62
- plus $511 from 21 others
What the payments were for
- Food & beverage$1,239100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 9 | $289 |
| Merit Medical Systems Inc | 4 | $114 |
| TELA Bio, Inc. | 7 | $113 |
| Elucent Medical | 1 | $81 |
| Davol Inc. | 3 | $70 |
| Johnson & Johnson | 3 | $62 |
| Conmed Corporation | 2 | $53 |
| Smith+Nephew | 2 | $45 |
| Stryker | 1 | $36 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Cumberland Pharmaceuticals, Inc. | 2 | $34 |
| Medtronic | 2 | $31 |
| Integra Lifesciences Corporation | 2 | $28 |
| Braintree Laboratories, Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Venclose Inc. | 1 | $18 |
| Cook Medical LLC | 1 | $18 |
| Solventum Corporation | 1 | $18 |
| Urgo Medical North America, LLC | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| AbbVie | 1 | $18 |
| Olympus America Inc. | 1 | $18 |
| Innocoll Pharmaceuticals Limited | 1 | $18 |
| Merck | 1 | $16 |
| Polynovo North America LLC | 1 | $15 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
How this compares
$1,239 in reported general payments places this provider in the 40th percentile of 382 surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 56 | $544 |
| Pantoprazole Sodium | 41 | $390 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $348 |
| Ondansetron Hcl | 77 | $250 |
| Omeprazole | 27 | $238 |
| Tramadol Hcl | 82 | $199 |
| Promethazine Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other surgery in Florence
- Daniel CoxBirmingham$1.2M
- John PorterfieldBessemer$972K
- Parker HuBirmingham$734K
- Barton WoodAlabaster$702K
- Forrest RingoldMobile$678K
- Adam BeckBirmingham$634K
- Jason BeaverDothan$374K
- Dennis FernandezHuntsville$266K
- Cameron AskewBirmingham$236K
- Terry TreadwellMontgomery$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.